QVT Associates GP LLC, 10% Owner at CONCERT PHARMACEUTICALS, INC. (CNCE), bought 559,999 shares at $14.00 ($4.2M) on 2014-02-19, disclosed to the SEC on 2014-02-21.
Open-market purchase of $4.2M CNCE by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 259,999 | $0 | 0.0% |
| 2 | $14.00 | 300,000 | $4.2M | 100.0% |
| Total | $7.50 avg | 559,999 | $4.2M | 100% |
| Filing → |
| UROV | BUY | 2019-06-03 | $278K | — | Filing → |
| UROV | BUY | 2019-05-29 | $110K | — | Filing → |
| UROV | BUY | 2019-05-23 | $326K | — | Filing → |